# Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal Carcinoma

> **NCT06762470** · — · ACTIVE_NOT_RECRUITING · sponsor: **Jiangxi Provincial Cancer Hospital** · enrollment: 325 (estimated)

## Conditions studied

- Histopathological Diagnosis of Nasopharyngeal Carcinoma
- Patients with Nasopharyngeal Carcinoma Without Distant Metastases After AJCC/UACC 8th Edition

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06762470
- **Lead sponsor:** Jiangxi Provincial Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 325 (ESTIMATED)
- **Last updated:** 2025-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06762470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06762470, "Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06762470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*